Education
About Us
Working with TipRanks
Follow Us
HeartBeam (BEAT)
NASDAQ:BEAT
Earnings Data
Report Date
May 07, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.14Last Year’s EPS
-0.18Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed meaningful de‑risking of the underlying technology (two FDA 510(k) clearances, working patch prototype, ALIGN ACS pilot enrollment, AI collaboration with Mount Sinai, and an initial commercial partner) and a disciplined cost posture. However, these operational and clinical achievements are balanced by material near‑term financial risk (only $4.4M cash on hand vs. projected $17M–$19M burn in 2026), uncertain regulatory pathway for the ACS indication, and the need to validate commercial adoption beyond a small concierge initial market. Overall, the company demonstrated strong technical and strategic progress but faces significant execution and funding risks that temper the outlook.Company Guidance
Regulatory Milestones — FDA Clearances
Received FDA 510(k) clearance in December 2025 for the 12-lead synthesis software for arrhythmia assessment and previously secured foundational 510(k) clearance for the HeartBeam system (Dec 2024); overturned an NSE in ~2.5 weeks demonstrating productive FDA engagement.
Product Development — Working 12‑Lead Patch Prototype
Unveiled a working on‑demand 12‑lead extended‑wear patch prototype; prospective clinical studies underway; patch integrates continuous single‑lead monitoring with instant 12‑lead capture via finger electrodes.
Commercial Launch and Early Go‑To‑Market Plan
Initiated limited commercial launch targeting concierge and preventive cardiology practices; hired CCO Brian Humbarger; signed first commercial partner ClearCardio; target price per patient $500–$1,000/year with goal of breakeven at ~30,000 patients and payback period of 3–5 months in accounts.
Clinical Validation — ALIGN ACS Pilot Study Started
Began enrollment in the ALIGN ACS European pilot study (~100 patients) comparing HeartBeam ECG to standard 12‑lead for heart attack detection; expected to inform design of a U.S. FDA pivotal study and projected pilot completion in 2026 (company expects rapid enrollment).
Market Research Supporting Patch Opportunity
Third‑party physician survey: 86% would shift some patches to a 12‑lead patch, averaging a 61% shift of prescriptions; 94% would shift other cardiac monitoring devices; 64% would prescribe more patches (avg +45%) — implying potential ~30% immediate market growth.
AI & Data Partnerships
Assembled AI team led by former Google Verily AI head and announced strategic collaboration with Mount Sinai to develop clinically annotated algorithms (initial focus includes heart attack assessment and wellness/ screening/prediction models).
Improved Cash‑flow Discipline
Net cash used in operating activities below $14.0M for full year 2025 and $2.9M in Q4 2025; company reports a 3% decrease year‑over‑year and a 30% decrease compared to the same quarter last year in operating cash usage, highlighting lower cash burn and a capital‑efficient operating model.
BEAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BEAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 12, 2026 | $1.47 | $1.36 | -7.48% |
Nov 13, 2025 | $1.57 | $1.56 | -0.64% |
Aug 13, 2025 | $1.20 | $1.11 | -7.50% |
May 13, 2025 | $1.71 | $1.60 | -6.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does HeartBeam (BEAT) report earnings?
HeartBeam (BEAT) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
What is HeartBeam (BEAT) earnings time?
HeartBeam (BEAT) earnings time is at May 07, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BEAT EPS forecast?
BEAT EPS forecast for the fiscal quarter 2026 (Q1) is -0.14.